Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Companyâ€™s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Companyâ€™s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Companyâ€™s main shareholder is Nordnet Pensionsforsakring.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Net sales - Rate of surprise

Company calendar

End-of-day quote NORDIC GROWTH MARKET Other stock markets 2024-01-31			5-day change	1st Jan Change
4.340 ^SEK	+6.90%		-.--%	-

06-16	Inhalation Sciences Secures SEK 0.4m Research Grant	FW
05-29	Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall	FW

Market Cap	11.52M 1.18M 1.04M 957K 894K 1.68M 112M 1.72M 4.45M 55.24M 4.45M 4.35M 192M	P/E 2024	-12.8x	P/E 2025	-12.4x
Enterprise Value	8.69M 893K 782K 722K 674K 1.27M 84.45M 1.3M 3.35M 41.66M 3.35M 3.28M 145M	EV / Sales 2024	5.6x	EV / Sales 2025	55x
Free-Float	94.25%	Yield 2024 *	-	Yield 2025	-

06-16	Inhalation Sciences Secures SEK 0.4m Research Grant	FW
05-29	Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall	FW
05-27	Inhalation Sciences working to secure additional funding	FW
05-18	Inhalation Sciences Sweden Wins Inhalation Research Services Order	MT
05-18	Inhalation Sciences secures order worth approximately SEK 1.3 million	FW
05-18	Inhalation Sciences Sweden AB Receives IRS Order Worth Approximately EUR 117,000	CI
05-11	Inhalation Sciences posts revenue and order intake growth in Q1	FW
05-11	Inhalation Sciences Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-24	Inhalation Sciences secures order worth SEK 350,000	FW
03-24	Inhalation Sciences Sweden AB Secures Additional PreciseInhale Service Orders Worth SEK 350,000	CI
03-03	Inhalation Sciences Raises SEK 2.88 Million Through Warrant Exercise and Directed Share Issue	FW
02-27	Inhalation Sciences Sees Decline in Revenue and Operating Profit – Starts 2026 with Strong Order Backlog	FW
02-27	Inhalation Sciences Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

05-18	Inhalation Sciences receives IRS order worth approximately EUR 117,000	AQ
03-24	Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	PU
03-24	Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	AQ
02-18	Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000	AQ
01-27	Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies	PU

Inhalation Sciences Sweden AB Stock NORDIC GROWTH MARKET

Stocks

ISAB

SE0009983893

Advanced Medical Equipment & Technology

Valuation: Inhalation Sciences Sweden AB

Latest news : Inhalation Sciences Sweden AB

Press Releases: Inhalation Sciences Sweden AB

Quotes and Performance

Managers and Directors: Inhalation Sciences Sweden AB

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Income Statement and Estimates

Net sales - Rate of surprise

Manager	Title	Age	Since
Manoush Masarrat CEO	Chief Executive Officer	-	2019-09-15
Per Magnus Gerde CTO	Chief Tech/Sci/R&D Officer	-	2004-12-31
Ulf Wedenberg PRN	Corporate Officer/Principal	-	2025-06-01

Director	Title	Age	Since
Per Magnus Gerde BRD	Director/Board Member	-	2004-12-31
Jan Hellqvist BRD	Director/Board Member	-	2022-08-31
Ulf Ericsson BRD	Director/Board Member	-	2024-08-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INHALATION SCIENCES SWEDEN AB	+6.90%	-.--%	-	-	1.19M
THERMO FISHER SCIENTIFIC, INC.	-1.82%	+8.23%	+23.86%	-2.37%	191B
INTUITIVE SURGICAL, INC.	+0.63%	+1.44%	-24.78%	+20.76%	143B
DANAHER CORPORATION	-2.06%	+8.04%	-2.55%	-19.04%	139B
BOSTON SCIENTIFIC CORPORATION	-0.99%	-0.98%	-59.13%	-17.63%	65.74B
EDWARDS LIFESCIENCES CORPORATION	+0.96%	+6.77%	+17.24%	-0.36%	52.27B
SIEMENS HEALTHINEERS AG	-0.47%	-1.28%	-27.62%	-32.66%	43.55B
AGILENT TECHNOLOGIES, INC.	-2.13%	+5.42%	+12.99%	+12.95%	38.41B
WATERS CORPORATION	-1.32%	+3.25%	+5.98%	+41.21%	36.76B
GE HEALTHCARE TECHNOLOGIES INC.	-1.47%	+7.04%	-12.37%	-17.50%	29.91B
Average	-0.15%	+4.59%	-7.38%	-1.63%	82.17B
Weighted average by Cap.	-1.00%	+5.58%	-4.32%	-1.67%

	2024	2025
Net sales	11.05M 1.14M 994K 918K 857K 1.61M 107M 1.65M 4.26M 52.97M 4.26M 4.17M 184M	3.04M 313K 274K 253K 236K 444K 29.56M 454K 1.17M 14.58M 1.17M 1.15M 50.63M
Net income	-5.15M -529K -463K -428K -399K -752K -50.03M -769K -1.99M -24.68M -1.99M -1.94M -85.69M	-10.16M -1.04M -915K -844K -788K -1.48M -98.75M -1.52M -3.92M -48.72M -3.92M -3.84M -169M
Net Debt	-4M -412K -360K -333K -311K -585K -38.91M -598K -1.55M -19.19M -1.55M -1.51M -66.64M	-2.83M -291K -255K -235K -220K -414K -27.52M -423K -1.09M -13.57M -1.09M -1.07M -47.13M